| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/24/2004 | WO2004052228A2 Pharmacological vitreolysis |
| 06/24/2004 | WO2004052177A2 Cell-based therapies for ischemia |
| 06/24/2004 | WO2004028469A3 Docohexaenoic acid for improved glycemic control |
| 06/24/2004 | WO2004026894A3 Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity |
| 06/24/2004 | WO2004024925A3 Collectin-complement activating protein chimeras |
| 06/24/2004 | WO2004022594A3 Immune modulatory compounds and methods |
| 06/24/2004 | WO2004021993A3 Modified asialo-interferons and uses thereof |
| 06/24/2004 | WO2004019863A3 Combination therapy for treatment of fibrotic disorders |
| 06/24/2004 | WO2004016641A3 Proteins involved in the regulation of energy homeostasis |
| 06/24/2004 | WO2004011650A3 Antigens encoded by alternative reading frame from pathogenic viruses |
| 06/24/2004 | WO2004011498A3 Long lasting natriuretic peptide derivatives |
| 06/24/2004 | WO2004006864A3 Methods and compositions for the enhancement of wound healing |
| 06/24/2004 | WO2004003507A3 Methods for identifying regulators of muscle mass using amylin receptors |
| 06/24/2004 | WO2004000231A3 Methods and compositions for the treament of cancer |
| 06/24/2004 | WO2003106481A8 A process of producing ala-gln dipeptide |
| 06/24/2004 | WO2003103699A8 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 06/24/2004 | WO2003100025A3 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003083083A3 Methods of using flt3-ligand in immunization protocols |
| 06/24/2004 | WO2003076631A3 Genetic products differentially expressed in tumors and use thereof |
| 06/24/2004 | WO2003075856A3 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea |
| 06/24/2004 | WO2003061559A9 Binding peptides specific for the extracellular domain of erbb2 and uses therefor |
| 06/24/2004 | WO2003057200A3 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| 06/24/2004 | WO2003050238A9 Receptor-targeted adenoviral vectors |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2003014309A3 Interleukin-1 receptors in the treatment of diseases |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002092758A9 Gastrokines and derived peptides including inhibitors |
| 06/24/2004 | WO2002086075A3 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 06/24/2004 | WO2002038141A3 Compositions and methods for treatment of mild cognitive impairment |
| 06/24/2004 | WO2002036072A3 Method for short-term and long-term drug dosimetry |
| 06/24/2004 | US20040123336 Using viral particles to improve effectiveness of gene transfer vehicle via inhibition of antigen presenting cells; somatic cell transformation and animal models for disease |
| 06/24/2004 | US20040122217 Lectin compositions and methods for modulating an immune response to an antigen |
| 06/24/2004 | US20040122216 A mutein recombinant tissue protective cytokine lacking at least one activity selected from group consisting of increasing hematocrit, vasoactive action, hyperactivating platelets, pro-coagulant activities and increasing production of thrombocytes |
| 06/24/2004 | US20040122215 Human Ependymin |
| 06/24/2004 | US20040122214 Glycoprotein conjugate for the prevention lymphadenopathy associated viral infection; viricides |
| 06/24/2004 | US20040122210 exerts a trophic effects on the small and large intestine via stimulation of cell proliferation and inhibition of apoptosis |
| 06/24/2004 | US20040122209 Products for regulating the degradation of collagen and methods for identifying same |
| 06/24/2004 | US20040122165 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 06/24/2004 | US20040122101 Polymorphs of suberoylanilide hydroxamic acid |
| 06/24/2004 | US20040122100 which contain EP1 agonist (which activate EP1 receptor that is subtype of prostaglandin E2 receptor) as an active ingredient |
| 06/24/2004 | US20040122077 Administering a statin drug in an amount to promote angiogenesis in the tissue, preferably in situations where the subject is not otherwise in need of the drug ; activating Akt (protein kinase B) in vascular endothelial cells in vitro and in vivo |
| 06/24/2004 | US20040122062 such as 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo-[4,3-c]pyridin-5-yl)-1-(R)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040122013 Analogs of nocicettin |
| 06/24/2004 | US20040121992 Therapeutic methods of reducing cholesterol accumulation |
| 06/24/2004 | US20040121977 Antisense modulation of activating transcription factor 3 expression |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121975 Hepatitis C virus assays |
| 06/24/2004 | US20040121972 Methylenetetrahydrofolate reductase inhibitors and uses thereof |
| 06/24/2004 | US20040121971 Therapeutic use of tumor necrosis factor-alpha mutein |
| 06/24/2004 | US20040121970 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 06/24/2004 | US20040121963 Composition for inhibiting hiv activity extracted from paecilomyces sp. (tochu-kaso) j300 |
| 06/24/2004 | US20040121961 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 06/24/2004 | US20040121960 For therapy of Alzheimer's and prion disease |
| 06/24/2004 | US20040121959 Comprises cyclic amino acid sequences for use in treatment and prevention of nervous system, inflammatory, pain, asthmatic, urogenital, skin and cancer disorders |
| 06/24/2004 | US20040121958 Methods of alleviating neuropathic pain |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121955 Methods for modulating angiogenesis |
| 06/24/2004 | US20040121953 Thrombopoiesis-stimulating proteins having reduced immunogenicity |
| 06/24/2004 | US20040121952 Treatment of cancer |
| 06/24/2004 | US20040121950 Drug comprising synthetic peptide analogs for the treatment of cancer |
| 06/24/2004 | US20040121949 For preparation of food additives or supplements in the medical field, as a source of easily assimilable amino acids useful for trophism of the osteo-articular system, scalp, nails and other particular tissues |
| 06/24/2004 | US20040121948 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 06/24/2004 | US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/24/2004 | US20040121946 For producing vaccines; therapy and prophylaxis of cancer |
| 06/24/2004 | US20040121945 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/24/2004 | US20040121944 Cyclosporin-based pharmaceutical compositions |
| 06/24/2004 | US20040121942 Inducing phospholamban deficiency for therapy of heart failure |
| 06/24/2004 | US20040121941 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 06/24/2004 | US20040121940 Anticancer prodrugs, enhance enzymatic activation rates |
| 06/24/2004 | US20040121468 Methods for regulating bud-hypha transitions and cAMP levels by the adenylate cyclase-associated protein gene, CAP1 |
| 06/24/2004 | US20040121463 Methods and compositions for modulating apoptosis |
| 06/24/2004 | US20040121443 Modified protamine with reduced immunogenicity |
| 06/24/2004 | US20040121438 Comprises nucleotide sequences coding matrix metalloprotease enzyme inhibitors for use in the treatment of injuries; wound healing agents |
| 06/24/2004 | US20040121429 Comprises polypeptide with angiotensin converting enzyme activity for us in identifying modulators for treatment of cardiovascular, arthrosclerotic and hypertensive disorders |
| 06/24/2004 | US20040121396 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040121376 Antisense modulation of interleukin-5 signal transduction |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121363 Novel variants of rankl protein |
| 06/24/2004 | US20040121357 Artificial endonuclease |
| 06/24/2004 | US20040121353 protein tyrosine phosphatase (TCPTP) for treating metabolic disorders (including diabetes and obesity), cancer, autoimmune disease, infectious and inflammatory disorders |
| 06/24/2004 | US20040121351 for diagnosing polymorphism in a tubulin molecule and for anticancer drug screening |
| 06/24/2004 | US20040121349 Novel 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor |
| 06/24/2004 | US20040121348 Compositions and methods for treating pancreatic cancer |
| 06/24/2004 | US20040121328 Modulation of phosphodiesterase 8A Expression |
| 06/24/2004 | US20040121327 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 06/24/2004 | US20040121326 Neuregulin-4; for treating or preventing a disease, condition or syndrome associated with disregulation of an endogenous protein affecting receptor activity |
| 06/24/2004 | US20040121325 Beta 1,2-xylosyltransferase-gene from arabidopsis |
| 06/24/2004 | US20040121009 Method of modifying the release profile of sustained release compositions |
| 06/24/2004 | US20040120997 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system |
| 06/24/2004 | US20040120989 Article for debridement and detoxification of wounds |
| 06/24/2004 | US20040120968 Methods for regulating bud-hypha transitions and cAMP levels in Candida albicans |
| 06/24/2004 | US20040120966 polypeptide comprises a C domain identical to a polypeptide that is a competitive inhibitor of bacterial adhesion of pneumococcal |
| 06/24/2004 | US20040120961 Saposin C and receptors as targets for treatment of benign and malignant disorders |
| 06/24/2004 | US20040120960 initial dosing of a therapeutically effective amount of an LFA-1 antagonist, followed by a subsequent intermittent dosing of a therapeutically effective amount of an LFA-1 antagonist |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |